Tag: BAFF-R blockade

FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease

The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…

ME Desk